Concepedia
Statistics
Publications
23
Citations
786
H-Index
16
Active since
1983
Affiliations
University of Chicago(Current)
Cancer Research Center
University of Illinois Chicago
N. J. Vogelzang is an author at University of Chicago specializing in oncology, medicine, and chemotherapy.
Publications per year
1983–2011
Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer.
Richard L. Schilsky, M. Eileen Dolan, Donna Bertucci et al. · PubMed · 2000 · 106 citations
Medicine, Oncology, Pharmacology +17
Dihydro-5-azacytidine and cisplatin in the treatment of malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B.
Brian L. Samuels, James E. Herndon, David C. Harmon et al. · PubMed · 1998 · 66 citations
Medicine, Oncology, Pharmacotherapy +11
Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma
Mebea Aklilu, Walter M. Stadler, Mary A. Markiewicz et al. · Annals of Oncology · 2004 · 62 citations · Full text
Life Sciences, Immunology, Oncology +15
A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors
Anjali Desai, Richard L. Schilsky, Aiping Young et al. · Annals of Oncology · 2005 · 59 citations
Medicine, Oncology, Pharmacology +9
A phase I trial of pharmacologic modulation of irinotecan with cyclosporine and phenobarbital
Federico Innocenti, Samir D. Undevia, Shaila K. Mani et al. · Clinical Pharmacology & Therapeutics · 2004 · 54 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
1–5 of 23